menu
Podcast
October 22, 2019

Next Generation Sequencing (NGS) for Influenza Vaccine Development

A new approach to seasonal flu vaccine development
In this new podcast episode, Q2 Solutions experts Wayne Hogrefe from our Vaccine Laboratory and Pat Hurban from our Genomics Laboratory discuss a new approach to influenza vaccine development: Next Generation Sequencing (NGS).



Related Services:
A Next Generation Sequencing Approach to Influenza Vaccine Development

NGS approach to strain identification and genomic characterization of influenza

Vaccine Laboratory Services

Test Menu

A Next Generation Sequencing (NGS) Approach to Influenza Vaccine Development

NGS influenza typing assay for vaccine and therapeutic development

Keeping Up with the Flu: Advances in seasonal influenza vaccine development

Read More